New Pneumococcal Vaccination Recommendations

Holly Harmon


Centers for Disease Control & Prevention (CDC) has released new pneumococcal vaccination recommendations. Adults 65 years of age or older are now recommended to get the pneumococcal conjugate vaccine (PCV13, Prevnar-13®) followed by the pneumococcal polysaccharide vaccine (PPSV23, Pneumovax®23) 6-12 months later.

Below are several resources to assist with communications regarding the new pneumococcal vaccination recommendations for adults 65 years or older:

· Short article informs readers about the new pneumococcal vaccination recommendation for adults 65 years or older and explains why it is important for older adults to be up-to-date on this and other vaccines recommended for them - “CDC Releases New Recommendations for Pneumococcal Vaccination” .   

· Factsheet to help healthcare professionals address common questions patients ask regarding pneumococcal vaccination. Click here to view the Pneumococcal Frequently Asked Questions factsheet. 

· Visit the CDC’s Pneumococcal Vaccination page.

 · Review the Morbidity & Mortality Weekly Report from CDC. Click here to read the MMWR article.